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ABSTRACT
dsRNA of several hundred nucleotides in
length is effective at interfering with gene ex-
pression in mouse oocytes, pre-implantation
embryos, and embryonic stem (ES) cells but
is not as efficient in differentiated cell lines.
Here we describe a method to achieve RNA
interference in totipotent and differentiated
ES cells together with a wide range of other
mammalian cell types that is both simple and
efficient. It utilizes a linearized plasmid that
directs the expression of a hairpin RNA with
a 22-nucleotide-paired region. This molecule
has a 13-nucleotide 5′ overhang that would
be subject to capping on its 5′ phosphoryl
group and thus differs from the ideal struc-
ture suggested for effective small interfering
RNAs. Thus, it appears either that the struc-
ture of small inhibitory RNA molecules may
not need to be as precise as previously
thought or that such a transcript is efficiently
processed to a form that is effective in inter-
fering with gene expression.
INTRODUCTION
The specific blocking gene expres-
sion by double-stranded RNA (dsRNA)
of up to several hundred nucleotides in
length has been documented in a vari-
ety of organisms including Caenorhab-
ditis elegans (1), Drosophila melano-
gaster (2), trypanosomes (3), planaria
(4), paramecium (5), hydra (6), ze-
brafish (7,8), and mouse (9,10). The
use of dsRNA of such molecular
weight for silencing gene expression
has not been as efficient in cultured
mammalian somatic cell lines where it
appears to also inhibit gene expression
nonspecifically (11). This reflects the
ability of dsRNA to trigger the interfer-
on response in mammalian cells, lead-
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ing to the activation of the RNA-depen-
dent protein kinase PKR and 2′,5′-
oligoadenylate synthetase (2′,5′-AS).
Activated PKR stalls translation by
phosphorylation of the initiation factor
eIF2, and activated 2′,5′-AS causes
mRNA degradation by 2′,5′-oligoad-
enylate-activated ribonuclease L (12).
These responses to introduction of any
dsRNA lead to an overall block of
translation and cell death. However,
three reports have now suggested such
longer dsRNAs can mediate RNA in-
terference (RNAi) without accompany-
ing interferon responses (13–15).
Longer dsRNA appears to mediate
specific RNAi efficiently in mouse
oocytes and embryos (9,10,16). Simi-
larly, embryonic stem (ES) cells, which
are derived from the mouse embryo,
seem to show a specific response to
RNAi with dsRNA of this size (17,18).
These findings suggest that either em-
bryonic cells have a more effective
RNAi response or that the interferon
response to dsRNA is absent or not yet
fully developed.
dsRNA with an average length of
500 bp has been typically delivered by
microinjection into embryos or syncy-
tial tissues or by transfecting cultured
cells with dsRNA. The efficiency of
this approach has recently been im-
proved by an electroporation approach
that can introduce dsRNA into multiple
mouse oocytes or embryos (16). In C.
elegans, RNAi is sufficiently robust
that the effects can be achieved by
feeding the worms an E. coli strain that
is expressing the specific dsRNA (19).
Interference with specific gene expres-
sion can also be achieved in stable
transgenic lines of D. melanogaster and
C. elegans by the expression of a con-
struct directing the production of a hair-
pin loop of RNA (20,21). Such con-
structs can be placed under the control
of regulatable promoters to interfere
with specific gene expression in a spa-
tiotemporal manner (21,22). 
An important clue to understanding
the mechanism of RNAi came from the
discovery that 21–23 nucleotide pieces
of dsRNA are intermediates that are
generated from the cleavage of longer
dsRNA (23). Such small dsRNAs
induce efficient sequence-specific
mRNA degradation in lysates prepared
from Drosophila embryos (23,24).
Moreover, when transfected into cul-
tured mammalian cell lines, small inter-
fering RNAs (siRNAs) of 23 nu-
cleotides appear to evade the interferon
response to elicit specific gene silenc-
ing (24,25). Recently, plasmids that di-
rect the synthesis of a small hairpin
RNA from an RNA polymerase III pro-
moter have been described (26–28).
The products are analogous to synthetic
siRNAs because they have 3′ over-
hanging T or U nucleotides but are
folded back on themselves to give a 19-
to 20-nucleotide base paired region and
a 4- to 9-nucleotide loop.
In this study, we describe a simple
and efficient method for the inhibition
of gene expression in mouse ES cells,
their differentiated derivatives, and in
somatic cell lines, by producing
siRNAs in vivo as short hairpin struc-
tures transcribed from an RNA poly-
merase II promoter. These RNAs are
most likely not polyadenylated, so they
may be an effective trigger for the
RNAi response. The effectiveness of
these transcripts suggests that either the
precise structure of siRNA molecules
may not be as critical as previously
thought (25) or that the structure of the
transcript per se facilitates its conver-
sion into effective siRNA.
Figure 1. Schematic view of the construct encoding for short hairpin GFP RNA. (A) Linearized pds-
GFP-N1 plasmid. Double-stranded synthetic DNA fragment was inserted between NheI and XbaI sites of
the pGFPesm-N1 plasmid, downstream of the CMV promoter. (B) The inserted synthetic DNA fragment
consisted of indirect repeats of a 22-nucleotide-long GFP sequence that were separated by an 18-nu-
cleotide-long spacer of three restriction sites. Flanking restriction sites were added to the insert to pro-
duce a NheI site at its 5′ end and a XbaI site at its 3′ end. (C) Predicted structure of the short hairpin RNA:
a 7-MeG cap is likely to be added to the 5′ ends of a large proportion of the transcripts. The 5′-transcribed
sequence preceding the NheI restriction site is marked in red and the target GFP sequence in green.
MATERIALS AND METHODS
Plasmid for dsRNA Production
Two oligonucleotides were synthe-
sized corresponding to an inverted se-
quence repeat of a 22-nucleotide frag-
ment of GFP carried in the pQBIgfp
vector (Qantum/Qbiogene, Montreal,
QC, Canada), 5′-GTGGAGAGGGTG-
AAGGTGATGC-3′, which extended
from nucleotides 92 to 113, relative to
the first nucleotide of the start codon.
The inverted repeats were separated by
three unique restriction sites (SpeI-
NotI-SalI), and additional unique re-
striction sites were added to both ends.
The two complementary oligonu-
cleotides were incubated at 80°C and
left until the temperature decreased to
30°C. After annealing, the resulting ds-
DNA fragment possessed an NheI re-
striction site at the 5′ end and a XbaI
restriction site at the 3′ end. The an-
nealed DNA was cloned between the
NheI and XbaI sites of the plasmid
pGFPemdN1 such that the inverted re-
peat was located downstream from the
cytomegalovirus (CMV) promoter and
upstream of the XbaI restriction site in
this construct (Figure 1). 
Cell Culture
Wild-type (CBB) ES cells (kindly
provided by Azim Surani, University of
Cambridge) and transgenic (β-actin) ES
cells expressing Mus musculis GFP
(MmGFP) under the β-actin promoter
(Zernicka-Goetz, unpublished data)
were grown on gelatinized plates in
DMEM/nut mixture F12 (Invitrogen,
Carlsbad, CA, USA) supplemented with
12% FBS (Invitrogen), 100 IU/mL
leukemia inhibitory factor (LIF)
(CHEMICON, Temecula, CA, USA),
L-glutamine, sodium bicarbonate, β-
mercaptoethanol, sodium pyruvate, and
nonessential amino acids (Invitrogen).
ES cells used for experiments were kept
in culture between 15 and 25 passages
from the isolation of ES cells from the
inner cell mass of the blastocyst. To in-
duce differentiation, LIF was removed
from the medium. The cells were trans-
fected 10 days after the induction of dif-
ferentiation.
STO cells were grown in modified
DMEM (Invitrogen) supplemented
with 10% FBS (Sigma, St. Louis, MO,
USA). NIH-3T3 cells were grown in
DMEM supplemented with 10% FBS
(both from Sigma). 
Transfection
Prior to transfection, the pdsGFP-N1
plasmid was linearized with XbaI. The
pCMV-nls LacZ plasmid was kindly
provided by Dr. Aaron Zorn (Universi-
ty of Cambridge). Synthetic 21-bp
siRNAs [kindly provided by J. Pearson
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(University of Cambridge)] correspond-
ing to nucleotides 469–489 of QBIgfp
and to nucleotides 489–509 of MmGFP
(relative to the first nucleotide of the
start codon) were chemically synthe-
sized and annealed (Dharmacon Re-
search, Lafayette, CO, USA). 
The cells were trypsinized 24 h be-
fore transfection at 80% confluency and
transferred to gelatinized 4-well dishes
(4 × 105 cells/well). In all experiments,
a constant amount of 3 µg DNA/well
was maintained by the addition of Blue-
script® plasmid when required. DNA
was transfected to adherent cells by
lipofection using the Transfast
Reagent (Promega, Madison, WI,
USA), according to the manufacturer’s
instructions. We used 1 µg each of
pQBIgfp, pCMV-nls LacZ, and pds-
GFP-N1 or 60 pmol siRNA per well,
with the exception of those in which the
amount of the pQBIgfp plasmid was re-
duced to 0.5 or 0.1 µg (see Results). For
each 1 µg DNA, we used 2 µL Trans-
fast Reagent in 200 µL serum-free
medium. After 1 h of incubation at
37°C in 5% CO2, 600 µL complete cell
culture medium were added, and the
cells were cultured for 24 h or longer, as
specified in the Results section.
Gene-Silencing Evaluation
To estimate changes in GFP fluores-
cence, the cells were observed under a
1024 scanning head (Bio-Rad Labora-
tories, Hercules, CA, USA) attached to
an Eclipse 800 microscope (Nikon,
Melville, NY, USA) using 10% [for
GFP from Quantum pQBIgfp (QGFP)]
or 3% (for MmGFP) of laser power.
To detect β-galactosidase activity
histochemically, the cells were fixed in
1% formaldehyde, 0.2% glutaralde-
hyde for 10 min, washed with PBS, and
incubated with X-gal (Sigma). 
To quantify β-galactosidase activity
using a Dynex MLX luminometer
(Dynex Technologies, Chantilly, VA,
USA), the cells were trypsinized,
washed twice with ice-cold PBS, and re-
suspended in lysate buffer (K2HPO4,
KH2PO4, dithiothreitol). The cells were
then subjected to the two cycles of freez-
ing in dry ice and thawing at 37°C and
centrifuged at 17 000× g for 5 min at
4°C. The supernatant was stored at 70°C
until use. For each lysate, the same
amount of protein was used for the lumi-
nescent measurements. β-galactosidase
expression was monitored with the Lu-
minescent β-Gal kit (BD Biosciences
Clontech, Palo Alto, CA, USA). 
RESULTS
dsRNA of 21–22 nucleotides medi-
ates efficient sequence-specific silenc-
ing in several mammalian cell lines and
has been termed siRNA (23). We
sought to test whether the interfering re-
sponse could be achieved by expressing
a 22-nucleotide short hairpin GFP RNA
from a CMV promoter carried on a
plamid vector. To avoid the synthesis of
unnecessarily long RNA, we linearized
the plasmid by cleavage at an XbaI site
distal to the inverted sequence repeat
before transfecting it into different cell
types derived from the mouse embryo.
This could have the advantage of direct-
ing the synthesis of non-polyadenylated
RNA that itself might facilitate the trig-
gering of an RNAi response.
We first tested the effects of intro-
ducing the pdsGFP-N1 plasmid into
wild-type ES cells that expressed GFP
transiently from an exogenous plasmid,
pQBIgfp. Co-transfection of ES cells
with pQBIgfp and the plasmid encod-
ing for short hairpin RNA, pdsGFP-N1,
resulted in the almost complete inhibi-
tion of GFP expression within 24 h
(Figure 2A). This was in contrast to
cells transfected only with the pQBIgfp
plasmid (Figure 2A). This inhibition of
GFP expression was similar in extent to
that observed following the co-transfec-
tion of cells with pQBIgfp plasmid and
cognate synthetic siRNA (data not
shown). In experimental groups trans-
fected with plasmid directing the ex-
pression of the short hairpin or with
siRNA, GFP fluorescence did not reap-
pear following up to five days of cul-
ture. In each of these experiments, we
included a plasmid pCMV-nls LacZ,
which directs the expression of β-galac-
tosidase from a CMV promoter, and as-
sayed for the activity of this enzyme at
intervals after trasfection. Although
both the plasmid that encoded short
hairpin GFP RNA and GFP siRNA re-
sulted in a diminution of GFP expres-
sion, we were unable to detect any de-
Figure 2. RNAi in ES cells. (A) Change in GFP fluorescence after RNAi in wild-type ES (CBB) cells.
The cells were transfected with 1 µg each of GFP plasmid and LacZ plasmid. Experimental groups were
additionally transfected with 1 µg pdsGFP plasmid (encoding short hairpin RNA) or siRNA for GFP
(data not shown). The upper panel shows the control transfected cells. The lower panel shows the cells
transfected with the plasmid encoding for short hairpin RNA. GFP silencing was already evident 24 h
after transfection. (B) Changes in GFP fluorescence after RNAi in transgenic ES cells expressing GFP
from the β-actin promoter (β-actin). The cells were transfected with 1 µg LacZ plasmid. The experimen-
tal group was additionally transfected with 1 µg pdsGFP plasmid (encoding short hairpin RNA) or
siRNA for GFP. The upper panels show the control transfected cells, and the lower panels show the cells
transfected with plasmid encoding for short hairpin RNA. GFP silencing resulted in a decrease of
MmGFP fluorescence intensity and became evident after five days of culture.
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crease in β-galactosidase activity (data
not shown). These results demonstrate
that short hairpin RNA produced in
vivo is as potent as siRNA in inhibiting
gene expression in ES cells directed
from exogenous plasmids. 
To assess the efficiency of these two
approaches on the expression of an en-
dogenous chromosomally located gene,
we used a line of ES cells that stably
express MmGFP from the β-actin pro-
moter. The transfection of these cells
with the pdsGFP-N1 resulted in a de-
crease in GFP fluorescence 4–5 days
following transfection (Figure 2B).
Similar results were obtained after the
transfection of GFP siRNA. The persis-
tence of MmGFP expression until four
days after transfection may largely re-
flect the levels of this stable form of
protein in cells at the onset of the ex-
periment. There was no decrease in the
levels of expression of β-galactosidase
from the pCMV-nls LacZ co-transfect-
ed into these cells with either plasmid
directing the expression of the short
hairpin or siRNA.
It has recently been shown that long
dsRNAs trigger the nonspecific inhibi-
tion of gene expression in differentiat-
ed cells derived from mouse ES cells
and in several cell lines of embryonic
origin (13,21). Thus, we sought to ex-
amine whether short hairpin RNA
could elicit specific RNAi in differenti-
ated cells derived from ES cells. For
this purpose, we induced the differenti-
ation of wild-type and GFP-transgenic
ES cells by removing LIF from the cul-
ture and then carried out transfections
10 days after removal of LIF. We found
that short hairpin RNA produced from
the pdsGFP-N1 plasmid to be effective
in silencing GFP from a co-transfected
plasmid (Figure 3A) and from a chro-
mosomally inserted GFP transgene
(Figure 3B). This effect was main-
tained for at least five days of culture
following transfection. Once again, we
could detect no depression of β-galac-
tosidase expression from co-transfected
pCMV-nls LacZ.
We also carried out a similar experi-
ment in which ES cells were co-trans-
fected with GFP-expressing plasmid
together with the plasmid encoding for
short hairpin RNA or with synthetic
siRNA and then induced to differenti-
Figure 3. RNAi in differentiated derivatives of ES cells. (A) Changes in GFP fluorescence after RNAi in
differentiated wild type ES cells (CBB). Cells were transfected with 1 µg each of GFP plasmid and LacZ
plasmid. The experimental group was additionally transfected with 1 µg pdsGFP plasmid (encoding for
short hairpin RNA) or siRNA for GFP (data not shown). GFP silencing was already evident 24 h after trans-
fection by the decrease in the number of fluorescent cells and was visible as a total loss of GFP fluorescence
after five days of culture. (B) Changes in GFP fluorescence after RNAi in differentiated transgenic ES cells
(β-actin). The cells were transfected by using 1 µg LacZ plasmid. The experimental group was additional-
ly transfected with 1 µg pdsGFP plasmid (encoding for short hairpin RNA) or siRNA for GFP. GFP silenc-
ing appeared 24 h after transfection as a decrease in intensity of GFP fluorescence and was visible as loss of
GFP fluorescence after five days of culture. (A and B) The upper panels show the control transfected cells,
and the bottom panels show the cells transfected with plasmid encoding for short hairpin RNA.
ate by removing LIF from the culture
medium 24 h after transfection. Such
differentiating ES cells ceased to ex-
press GFP 48 h after LIF removal, and
this drop in GFP expression was main-
tained up to six days after LIF removal
(data not shown). Thus, the silencing of
GFP expression induced by in vivo
transcription of short hairpin RNA is
maintained after the induction of ES
cell differentiation.
Finally, we decided to test whether
the short GFP hairpin RNA would in-
terfere with GFP expression in somatic
cell lines. To this end, we co-transfected
mouse fibroblasts (NIH-3T3) and fetal
fibroblasts (STO) with GFP-expressing
plasmid and plasmid directing the syn-
thesis of short hairpin RNA. We found
that STO cells showed little or no ex-
pression of GFP 24 h after transfection
compared to the control cells. Similar
results were observed after the transfec-
tion of cells with cognate siRNA (Fig-
ure 4A). In contrast, we found that
equivalent amounts of siRNA oligonu-
cleotides or plasmid-expressing hairpin
RNA were less effective at interfering
with the extremely efficient expression
of GFP from the pQBIgfp plasmid
transfected into NIH-3T3 cells (Figure
4B). However, when we increased the
ratio of plasmid encoding for short hair-
pin RNA to pQBIgfp plasmid using 0.5
or 0.1 µg pQBIgfp plasmid instead of 1
µg, we began to see an interfering effect
on GFP expression. Transfection of
NIH-3T3 cells with pGFPds-N1 plas-
mid caused a significant decrease in the
GFP fluorescence in a large number of
cells, which was especially visible
when a 10:1 ratio of pdsGFP-N1 and
pQBIgfp plasmids was used (Figure
4B). A similar dose response was seen
with siRNA. There was no decrease in
the expression from the co-transfected
lacZ gene in these experiments.
DISCUSSION
Several reports have shown that it is
possible to inhibit gene expression in
cultured mammalian cells by the intro-
duction of long dsRNA. It seems partic-
ularly effective in totipotent and pluripo-
tent cells. This is perhaps not surprising
because sequence-specific RNAi by
long dsRNA was demonstrated to be ef-
fective in the cells of the mouse embryo
(9,10,14). Recently, long dsRNA has
been shown to produce an efficient spe-
cific response in undifferentiated ES and
embryonic carcinoma (EC) cells but not
when differentiation is induced (13,18).
Results with long dsRNA have been
more varied, leading to an unspecific re-
sponse in several mammalian cell types,
including mouse embryonic fibroblasts
(STO), and several pluripotent cell lines,
including N-Tera-1 and F9 cells (13,18).
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Figure 4. RNAi in somatic murine cells 24 h after transfection. (A) Changes in GFP fluorescence in
STO cells. Cells were transfected with 1 µg each of GFP plasmid and LacZ plasmid. The experimental
group was additionally transfected using 1 µg pdsGFP plasmid (encoding for short hairpin RNA) or
siRNA for GFP. The upper panel shows the control transfected cells; the middle panel shows the cells
transfected with plasmid encoding for short hairpin RNA; and the lower panel shows the cells transfect-
ed with siRNA for GFP. GFP silencing is evident from the reduced number of fluorescent cells. (B)
Changes in GFP fluorescence in NIH-3T3 cells. The cells were transfected with 1 (first column), 0.5
(second column) or 0.1 µg (third column) GFP plasmid, respectively, and 1 µg LacZ plasmid. The ex-
perimental group was additionally transfected with 1 µg pdsGFP plasmid (encoding for short hairpin
RNA) or siRNA for GFP. The upper panels show the control transfected cells; the middle panels show
the cells transfected with plasmid encoding short hairpin RNA; and the bottom panels show the cells
transfected with siRNA for GFP. GFP silencing is evident from the loss in the number of fluorescent
cells, the most evident in the group was transfected with 0.1 µg GFP-expressing plasmid (third column). 
However, three groups have reported
specific effects with long dsRNA
(13–15). On the other hand, siRNAs
produced in vitro induce a robust specif-
ic response in several cell lines includ-
ing human embryonic kidney (293),
HeLa cells, and NIH-3T3 cells (25,29).
This confirmed that the mechanism for
RNAi exists in mammalian cells and
suggests that it can be evoked most effi-
ciently if other effects mediated by
longer dsRNA can be bypassed. Here
we have shown that short hairpin RNA
produced in vivo leads to the efficient
and specific inhibition of gene expres-
sion not only in ES cells but also in their
differentiating or differentiated deriva-
tives and in mouse fibroblasts (STO and
NIH-3T3). In each case, the effect was
as potent as the effect of siRNA. Thus,
this approach offers a simple alternative
method for the inhibition of gene ex-
pression in many cell types.
It has been shown previously that
siRNAs mediate the efficient sequence-
specific mRNA degradation in lysates
prepared from Drosophila embryos and
in mammalian cells (23–25). These re-
ports suggested that the presence of
overhanging 3′ ends in synthetic
siRNAs are necessary to induce RNAi
in examined cells. Moreover, Harborth
and colleagues (29) found that a 5′
phosphate on the target complementary
strand of the siRNA duplex was re-
quired for siRNA function. An alterna-
tive system for expressing small
siRNA-like structures from a plasmid
has recently been described (26,27,
30–32). It attempts to emulate the syn-
thetic siRNAs described by Elbashir
and colleagues (25). Importantly, this
uses the RNA polymerase III promoter
and thus produces a transcript that is
neither capped nor polyadenylated. The
constructs that were effective in elicit-
ing dsRNAi and a 19-nucleotide paired
region had two 3′ overhanging T or U
residues, as specified by Elbashir et al.
(24). However, in our case, short hair-
pin RNA produced in cells from lin-
earized plasmid should have five un-
paired residues at its 3′ end. In fact,
these molecules also have 13-nu-
cleotide 5′ overhangs and are of a
length such that a high proportion of
them are highly likely to have 7MeG 5′
caps typical of RNA polymerase II
transcripts. Despite these significant
differences in the structure of siRNA
and short hairpin RNA, our results
show that both are equally effective at
interfering with gene expression. We
speculate that these hairpin structures
can function as siRNAs or are efficient-
ly processed into siRNA molecules.
They might also be particularly effi-
cient since being produced intracellu-
larly with a 5′ cap, they might evade the
interferon response. Furthermore, it is
possible that they are not recognized as
“foreign” RNA molecules because they
resemble the stem-loop structures of
small temporal RNAs (stRNAs)
(33,34) or microRNAs (miRNAs)
(35,36) that have been proposed to
have regulatory roles for eukaryotic
gene expression. Indeed, some features
of the miRNAs were recently incorpo-
rated into a system for carrying out
RNAi in cultured human cells (37). In
conclusion, the technique we described
presents a very effective, simple, and
low-cost method to knock down gene
expression in all mammalian cell types. 
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